BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12622625)

  • 1. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
    Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
    Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of PUVA erythema.
    Man I; Ibbotson SH
    J Dermatolog Treat; 2002 Dec; 13(4):179-83. PubMed ID: 19753738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the immersion time of PUVA bath therapy be shortened?
    Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
    Acta Derm Venereol; 2002; 82(1):18-20. PubMed ID: 12013191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
    Ibbotson SH; Dawe RS; Farr PM
    J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
    Azurdia RM; Dean MP; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
    Schempp CM; Schöpf E; Simon JC
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal phototoxic dose (MPD) measurements for topical photochemotherapy using a semiautomated MPD tester.
    Al-Ismail D; Edwards C; Al-Ofi O; Anstey AV
    Br J Dermatol; 2013 Sep; 169(3):687-9. PubMed ID: 23607709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy.
    Ibbotson SH; Dawe RS; Dinkova-Kostova AT; Weidlich S; Farr PM; Ferguson J; Wolf CR; Smith G
    Br J Dermatol; 2012 Feb; 166(2):380-8. PubMed ID: 21967523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
    Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
    Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The time-course of psoralen ultraviolet A (PUVA) erythema.
    Ibbotson SH; Farr PM
    J Invest Dermatol; 1999 Sep; 113(3):346-50. PubMed ID: 10469332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.